FDA Inspection 1073456 — FXM Clinical Research Miami LLC
The FDA completed an inspection of FXM Clinical Research Miami LLC on Nov 21, 2018 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 21, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami, FL (United States)
Additional details
Clinical BA/BE